Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

Bioconductor: open software development for computational biology and bioinformatics

Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082

Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829

Exploring the full spectrum of macrophage activation

Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144

Macrophage Diversity Enhances Tumor Progression and Metastasis

Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,349

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Bielack, S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.776 · Cited by 2,391

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125

lumi : a pipeline for processing Illumina microarray

Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,028

How dying cells alert the immune system to danger

Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737

Immunological aspects of cancer chemotherapy

Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712

Immunohistochemical Analysis of Inflammatory Cells in Benign and Precancerous Lesions and Carcinoma of the Prostate

Fujii, T., Shimada, K., Asai, O., Tanaka, N., Fujimoto, K., Hirao, K., & Konishi, N. (2013) · Pathobiology · doi:10.1159/000342396 · Cited by 57

Bone sarcomas in the immunotherapy era

Heymann, M., Schiavone, K., & Heymann, D. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14999 · Cited by 60

MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion

Wang, Q., Cai, J., Wang, J., Xiong, C., & Zhao, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2600-y · Cited by 56

Novel Immunotherapies for Osteosarcoma

Lu, Y., Zhang, J., Chen, Y., Kang, Y., Liao, Z., He, Y., & Zhang, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.830546 · Cited by 59

Multispectral Imaging

Mansfield, J. R. (2013) · Veterinary Pathology · doi:10.1177/0300985813506918 · Cited by 56

Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma

Evdokimova, V. E., Gassmann, H., Radvanyi, L. G., & Burdach, S. E. G. (2022) · Cancers · doi:10.3390/cancers15010272 · Cited by 58

Identifying osteosarcoma metastasis associated genes by weighted gene co-expression network analysis (WGCNA)

Tian, H., Guan, D.-H., & Li, J. (2018) · Medicine · doi:10.1097/md.0000000000010781 · Cited by 54

Macrophages, Neutrophils, and Cancer: A Double Edged Sword

Mantovani, A. (2014) · New Journal of Science · doi:10.1155/2014/271940 · Cited by 55

Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis

Nirala, B. K., Yamamichi, T., Petrescu, D. I., Shafin, T. N., & Yustein, J. T. (2023) · Cancers · doi:10.3390/cancers15205108 · Cited by 53

Matrix‐Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis

Zandueta, C., Ormazabal, C., Perurena, N., Martínez-Canarias, S., Zalacaín, M., San-Julián, M., Grigoriadis, A. E., Valencia, K., Campos-Laborie, F. J., Rivas, J. D. L., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4740 · Cited by 51

Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer

Li, J., Yu, X.-J., Wang, Y., Huang, L., Liu, C., Zheng, L., Fang, Y., & Xu, J. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1139-2 · Cited by 51

G enetic and clonal dissection of osteosarcoma progression and lung metastasis

Xu, H., Zhu, X., Bao, H., Shek, T. W., Huang, Z., Wang, Y., Wu, X., Wu, Y., Chang, Z., Wu, S., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31389 · Cited by 51

Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies

Kostine, M., Bruijn, I. H. B., Cleven, A. H. G., Vervat, C., Corver, W. E., Schilham, M. W., van Beelen, E., van Boven, H., Haas, R. L., Italiano, A., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1386828 · Cited by 50

Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma

Withers, S. S., Skorupski, K. A., York, D. S., Choi, J. W., Woolard, K., Amorim, R. L., Sparger, E. E., Rodriguez, C. O., McSorley, S. J., Monjazeb, A. M., et al. (2018) · Veterinary and Comparative Oncology · doi:10.1111/vco.12444 · Cited by 52

Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma

Yang, Q., Chen, T., Yao, Z., & Zhang, X. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-1789-z · Cited by 49

Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma

Negri, G. L., Grande, B. M., Delaidelli, A., El-Naggar, A. M., Cochrane, D. R., Lau, C. C., Triche, T. J., Moore, R. A., Jones, S. J. M., Montpetit, A., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5319 · Cited by 51

Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma

Chim, L. K., Williams, I. L., Bashor, C. J., & Mikos, A. G. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122076 · Cited by 47

Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans

Mannheimer, J., Tawa, G. J., Gerhold, D. L., Braisted, J. C., Sayers, C. M., McEachron, T. A., Meltzer, P. S., Mazcko, C. N., Beck, J. A., & LeBlanc, A. K. (2023) · Communications Biology · doi:10.1038/s42003-023-05208-z · Cited by 52

Description of the immune microenvironment of chondrosarcoma and contribution to progression

Simard, F. A., Richert, I., Vandermoeten, A., Decouvelaere, A., Michot, J., Caux, C., Blay, J., & Dutour, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1265716 · Cited by 47

Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes

Yahiro, K., Matsumoto, Y., Yamada, H., Endo, M., Setsu, N., Fujiwara, T., Nakagawa, M., Kimura, A., Shimada, E., Okada, S., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02508-9 · Cited by 47

Osteosarcoma in Children: Not Only Chemotherapy

Argenziano, M., Tortora, C., Pota, E., Paola, A. D., Martino, M. D., Leva, C. D., Pinto, D., & Rossi, F. (2021) · Pharmaceuticals · doi:10.3390/ph14090923 · Cited by 48

The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma

Mohseny, A. B., Cai, Y., Kuijjer, M. L., Xiao, W., van den Akker, B., de Andrea, C. E., Jacobs, R. J., ten Dijke, P., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.018 · Cited by 46

Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma

Wagner, F., Holzapfel, B. M., McGovern, J., Shafiee, A., Baldwin, J., Martine, L. C., Lahr, C. A., Wunner, F. M., Friis, T., Bas, O., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.030 · Cited by 46

Comparative Immunology and Immunotherapy of Canine Osteosarcoma

Mason, N. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_14 · Cited by 46

Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes

Liu, W., Xie, X., Qi, Y., & Wu, J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.19132 · Cited by 46

Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell ‘don't eat me’ signals off and ‘eat me’ signals on

Mohanty, S., Aghighi, M., Yerneni, K., Theruvath, J. L., & Daldrup-Link, H. E. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12556 · Cited by 46

An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis

Goldstein, S. D., Hayashi, M., Albert, C. M., Jackson, K. W., & Loeb, D. M. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9738-x · Cited by 45

RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma

Chen, S., Zeng, J., Huang, L., Peng, Y., Yan, Z., Zhang, A., Zhao, X., Li, J., Zhou, Z., Wang, S., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03415-6 · Cited by 44

Inhibition of macrophage polarization prohibits growth of human osteosarcoma

Xiao, Q., Zhang, X., Wu, Y., & Yang, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-2005-y · Cited by 44

Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection

Shu, Q., Ge, Y., Ma, H., Gao, X., Pan, J., Liu, D., Xu, G., Ma, J., & Jia, W. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12787 · Cited by 44

Immune Contexture of Pediatric CancersPreprint

Thakur, M. D., Franz, C., Brennan, L., Brouwer‐Visser, J., Tam, R., Korski, K., Koeppen, H., Ziai, J. M., Babitzki, G., Ranchère‐Vince, D., et al. (2022) · SSRN Electronic Journal · doi:10.1016/j.ejca.2022.03.012 · Cited by 44

Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling

Fan, H., Lu, S., Wang, S., & Zhang, S. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10323 · Cited by 43

lionessR: single sample network inference in R

Kuijjer, M. L., Hsieh, P., Quackenbush, J. F., & Glass, K. (2019) · BMC Cancer · doi:10.1186/s12885-019-6235-7 · Cited by 43

The immune landscape of chondrosarcoma - potential for therapeutic targeting of CSFR1+ macrophages

Richert, I., Gomez‐Brouchet, A., Bouvier, C., Pinieux, G. D. B. D., Karanian, M., Blay, J., & Dutour, A. (2019) · Journal of bone oncology · doi:10.1016/j.jbo.2019.100271 · Cited by 43

Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma

Chen, Y., Zhao, B., & Wang, X. (2020) · BMC Cancer · doi:10.1186/s12885-020-07536-3 · Cited by 44

Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma

Yapar, A., Tokgöz, M. A., Yapar, D., Atalay, İ. B., Ulucaköy, C., & Güngör, B. Ş. (2021) · Joint Diseases and Related Surgery · doi:10.52312/jdrs.2021.79775 · Cited by 43

Integrative analysis of immune‐related multi‐omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma

Shi, D., Mu, S., Pu, F., Liu, J., Zhong, B., Hu, B., Ni, N., Wang, H., Luu, H. H., Haydon, R. C., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13160 · Cited by 43

Global Gene Expression Profiling of Human Osteosarcomas Reveals Metastasis-Associated Chemokine Pattern

Namløs, H. M., Kresse, S. H., Müller, C. R., Henriksen, J. M., Holdhus, R., Sæter, G., Bruland, Ø. S., Bjerkehagen, B., Steen, V. M., & Myklebost, O. (2012) · Sarcoma · doi:10.1155/2012/639038 · Cited by 42

Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival

Zhang, H., Guo, L., Zhang, Z., Sun, Y., Kang, H., Song, C., Liu, H., Lei, Z., Wang, J., Mi, B., et al. (2019) · Journal of Cancer · doi:10.7150/jca.32092 · Cited by 41

A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma

Wu, G., & Zhang, M. (2020) · BMC Cancer · doi:10.1186/s12885-020-06741-4 · Cited by 41

Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs

Ammons, D. T., Hopkins, L. S., Cronise, K. E., Kurihara, J. N., Regan, D. P., & DOW, S. W. (2024) · Communications Biology · doi:10.1038/s42003-024-06182-w · Cited by 44

CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer

Buldakov, M. A., Zavyalova, M. V., Krakhmal, N. V., Телегина, Н. С., Vtorushin, S. V., Larionova, I., Riabov, V., Yin, S., Song, B., Чердынцева, Н. В., et al. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.09.011 · Cited by 40

Tumor-associated macrophages in human breast cancer parenchyma negatively correlate with lymphatic metastasis after neoadjuvant chemotherapy

Larionova, I., Zavyalova, M. V., Телегина, Н. С., Buldakov, M. A., Riabov, V., Чердынцева, Н. В., & Kzhyshkowska, J. G. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.08.001 · Cited by 41

Leucine and branched-chain amino acid metabolism contribute to the growth of bone sarcomas by regulating AMPK and mTORC1 signaling

Martin, S. B., Reiche, W. S., Fifelski, N. A., Schultz, A., Stanford, S. J., Martin, A. A., Nack, D. L., Radlwimmer, B., Boyer, M. P., & Ananieva, E. A. (2020) · Biochemical Journal · doi:10.1042/bcj20190754 · Cited by 40

Data-Driven Mathematical Model of Osteosarcoma

Le, T., Su, S., Kirshtein, A., & Shahriyari, L. (2021) · Cancers · doi:10.3390/cancers13102367 · Cited by 39

Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review

Jimmy, R., Stern, C., Lisy, K., & White, S. (2017) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2016-003105 · Cited by 39

Osteosarcoma tumor microenvironment: the key for the successful development of biologically relevant 3D in vitro models

Rodrigues, J., Sarmento, B. F. C. C., & Pereira, C. L. (2022) · In vitro models · doi:10.1007/s44164-022-00008-x · Cited by 41

CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients

Sand, L. G. L., Scotlandi, K., Berghuis, D., Snaar-Jagalska, E. B., Picci, P., Schmidt, T., Szuhai, K., & Hogendoorn, P. C. W. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.08.020 · Cited by 39

Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation

Wunder, J. S., Lee, M. J., Nam, J., Lau, B. Y., Dickson, B. C., Pinnaduwage, D., Bull, S. B., Ferguson, P. C., Seto, A. J., Gökgöz, N., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1737385 · Cited by 38

Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma

Tsuda, Y., Tsoi, K. M., Parry, M., Stevenson, J. D., Fujiwara, T., Sumathi, V. P., & Jeys, L. M. (2020) · The Bone & Joint Journal · doi:10.1302/0301-620x.102b6.bjj-2019-1307.r1 · Cited by 38

A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy

Pan, R., Pan, F., Zeng, Z., Lei, S., Yang, Y., Yang, Y., Hu, C., Chen, H., & Tian, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1017120 · Cited by 38

Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model

Barøy, T., Kresse, S. H., Skårn, M., Stabell, M., Castro, R., Lauvrak, S. U., Llombart‐Bosch, A., Myklebost, O., & Meza‐Zepeda, L. A. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-93 · Cited by 37

Network regularised Cox regression and multiplex network models to predict disease comorbidities and survival of cancer

Xu, H., Moni, M. A., & Lió, P. (2015) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2015.08.010 · Cited by 37

Using the Spleen as anIn VivoSystemic Immune Barometer Alongside Osteosarcoma Disease Progression and Immunotherapy withα-PD-L1

Markel, J., Noore, J., Emery, E. J., Bobnar, H. J., Kleinerman, E. S., & Lindsey, B. A. (2018) · Sarcoma · doi:10.1155/2018/8694397 · Cited by 38

HACE1 is a potential tumor suppressor in osteosarcoma

El-Naggar, A. M., Clarkson, P. W., Negri, G. L., Turgu, B., Zhang, F., Anglesio, M. S., & Sorensen, P. H. B. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1276-4 · Cited by 37

Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice

Shekhar, T. M., Burvenich, I. J. G., Harris, M. A., Rigopoulos, A., Zanker, D. J., Spurling, A., Parker, B. S., Walkley, C. R., Scott, A. M., & Hawkins, C. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-6103-5 · Cited by 37

Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages

Reis-Sobreiro, M., da Mota, A. T., Jardim, C., & Serre, K. (2021) · Cells · doi:10.3390/cells10092364 · Cited by 44

Tumor-associated macrophages in osteosarcoma

Zhao, Y., Zhang, B., Zhang, Q., Ma, X., & Feng, H. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100029 · Cited by 37

mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts

Kuijjer, M. L., Namløs, H. M., Hauben, E. I., Machado, I., Kresse, S. H., Serra, M., Llombart‐Bosch, A., Hogendoorn, P. C. W., Meza‐Zepeda, L. A., Myklebost, O., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-66 · Cited by 37

Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index

Wang, Y., Ma, X., Xu, E., Huang, Z. Y., Chen, Y., Zhu, K., Dong, Y., & Zhang, C. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1586 · Cited by 36

L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.

Biteau, K., Guiho, R., Chatelais, M., Taurelle, J., Chesneau, J., Corradini, N., Heymann, D., & Rédiní, F. (2016) · PubMed Central · Cited by 36

Genome‐wide association study identifies the GLDC / IL33 locus associated with survival of osteosarcoma patients

Koster, R., Panagiotou, O. A., Wheeler, W. A., Karlins, E., Gastier, J. M., de Toledo, S. R. C., Petrilli, A. S., Flanagan, A. M., Tirabosco, R., Andrulis, I. L., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31195 · Cited by 37

Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma

Yang, B., Su, Z., Chen, G., Zeng, Z., Tan, J., Wu, G., Zhu, S., & Lin, L. (2021) · Oncology Letters · doi:10.3892/ol.2021.12441 · Cited by 36

Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs

Brady, R. V., & Thamm, D. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1176807 · Cited by 35

Clinical and translational implications of immunotherapy in sarcomas

Recine, F., Vanni, S., Bongiovanni, A., Fausti, V., Mercatali, L., Miserocchi, G., Liverani, C., Pieri, F., Casadei, R., Cavaliere, D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1378398 · Cited by 35

Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma

Sun, Y., Jiang, X., Lü, Y., Zhu, J., Yu, L., Ma, B., & Zhang, Q. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.09.013 · Cited by 35

Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients

Hu, C., Liu, C., Tian, S., Wang, Y., Shen, R., Rao, H., Li, J., Yang, X., Chen, B., & Lin, Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-07216-2 · Cited by 35

Tumor‐Induced Local and Systemic Impact on Blood Vessel Function

Cedervall, J., Dimberg, A., & Olsson, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/418290 · Cited by 36

N-α-acetyltransferase 10 protein promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas

Chien, M., Lee, W.-J., Yang, Y., Tan, P., Pan, K., Liu, Y., Tsai, H., Hsu, C., Wen, Y., Hsiao, M., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.033 · Cited by 34

Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes

Patkar, S., Mannheimer, J., Harmon, S. A., Ramirez, C. J., Mazcko, C. N., Choyke, P. L., Brown, G. T., Türkbey, B., LeBlanc, A. K., & Beck, J. A. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1854 · Cited by 35

Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma

Kanno, H., Nishihara, H., Wang, L., Yuzawa, S., Kobayashi, H., Tsuda, M., Kimura, T., Tanino, M. A., Terasaka, S., & Tanaka, S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not028 · Cited by 33

The Role of Macrophages in Sarcoma Tumor Microenvironment and Treatment

Zając, A. E., Czarnecka, A. M., & Rutkowski, P. L. (2023) · Cancers · doi:10.3390/cancers15215294 · Cited by 32

Identification of a Novel Prognostic Gene Signature From the Immune Cell Infiltration Landscape of Osteosarcoma

Fan, L., Ru, J., Liu, T., & Ma, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.718624 · Cited by 32

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma

Wu, Z., Zhang, X., Chen, D., Li, Z., Wu, X., Wang, J., & Deng, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.806189 · Cited by 32

A risk signature‐based on metastasis‐associated genes to predict survival of patients with osteosarcoma

Shi, Y., He, R., Zhuang, Z., Ren, J., Wang, Z., Liu, Y., Wu, J., Jiang, S., & Wang, K. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29622 · Cited by 31

Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis

Li, M., Jin, X., Li, H., Wu, G., Wang, S., Yang, C., & Deng, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-6542-z · Cited by 31

Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients

Yang, M., Ma, X., Wang, Z., Zhang, T., Hua, Y., & Cai, Z. (2021) · Aging · doi:10.18632/aging.202958 · Cited by 31

An osteosarcoma zebrafish model implicates Mmp‐19 and Ets‐1 as well as reduced host immune response in angiogenesis and migration

Mohseny, A. B., Xiao, W., Carvalho, R., Spaink, H. P., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2012) · The Journal of Pathology · doi:10.1002/path.3998 · Cited by 32

A Validated Preclinical Animal Model for Primary Bone Tumor Research

Wagner, F., Holzapfel, B. M., Thibaudeau, L., Straub, M., Ling, M., Grifka, J. K., Loessner, D., Lévesque, J.-P., & Hutmacher, D. W. (2016) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.15.00920 · Cited by 31

Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion.

Lo, U., Bao, J., Cen, J., Yeh, H., Luo, J., Tan, W., & Hsieh, J. (2019) · Europe PMC (PubMed Central) · Cited by 30

Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?

Gomez‐Brouchet, A., Gilhodes, J., Acker, N. V., Brion, R., Bouvier, C., Assémat, P., Gaspar, N., Aubert, S., Guinebretière, J., Marie, B., et al. (2021) · Cancers · doi:10.3390/cancers13030423 · Cited by 30

Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis

Cai, Y., Wang, X., Wang, N., Wu, J., Ma, L., Xie, X., Zhang, H., Dang, C., Kang, H., Zhang, S., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119505 · Cited by 30

MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma

Nirala, B. K., Patel, T. D., Kurenbekova, L., Shuck, R. L., Dasgupta, A., Rainusso, N. C., Coarfa, C., & Yustein, J. T. (2023) · JCI Insight · doi:10.1172/jci.insight.164947 · Cited by 30

Pivotal role of IL-8 derived from the interaction between osteosarcoma and tumor-associated macrophages in osteosarcoma growth and metastasis via the FAK pathway

Tatsuno, R., Ichikawa, J., Komohara, Y., Pan, C., Kawasaki, T., Enomoto, A., Aoki, K., Hayakawa, K., Iwata, S., Jubashi, T., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06487-y · Cited by 29

Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma

Withers, S. S., York, D. S., Choi, J. W., Woolard, K., Amorim, R. L., Sparger, E. E., Burton, J. H., McSorley, S. J., Monjazeb, A. M., Murphy, W. J., et al. (2019) · Veterinary and Comparative Oncology · doi:10.1111/vco.12459 · Cited by 29

NK cell and macrophages confer prognosis and reflect immune status in osteosarcoma

Yang, X., Zhang, W., & Xu, P. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28167 · Cited by 28

Prognostic scoring system for osteosarcoma using network‐regularized high‐dimensional Cox‐regression analysis and potential therapeutic targets

Goh, T. S., Lee, J. S., Kim, J. I., Park, Y. G., Pak, K., Jeong, D. C., Oh, S., & Kim, Y. H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28065 · Cited by 28

Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma

Li, B., Li, G., Yan, X., Zhu, D., Lin, P. P., Wang, Z., Qu, H., He, X., Fu, Y., Zhu, X., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1893 · Cited by 28

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma

Cascini, C., Ratti, C., Botti, L., Parma, B., Cancila, V., Salvaggio, A., Meazza, C., Tripodo, C., Colombo, M. P., & Chiodoni, C. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02731-z · Cited by 28

Expression of the immune regulation antigen CD70 in osteosarcoma

Pahl, J. H. W., Santos, S. J., Kuijjer, M. L., Boerman, G. H., Sand, L. G. L., Szuhai, K., Cleton-Jansen, A., Egeler, R. M., Bovée, J. V. M. G., Schilham, M. W., et al. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0181-5 · Cited by 28

40 YEARS OF IGF1: IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapy

Mancarella, C., & Scotlandi, K. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0250 · Cited by 28

Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity

Choi, S. H., Myers, J., Tomchuck, S. L., Bonner, M., Eid, S. K., Kingsley, D., VanHeyst, K. A., Kim, S., Kim, B., & Huang, A. Y.-C. (2024) · 癌症：英文版 · doi:10.1002/cac2.12589 · Cited by 29

CAR T targets and microenvironmental barriers of osteosarcoma

Zhu, J., Simayi, N., Wan, R., & Huang, W. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2021.12.010 · Cited by 27

Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma

Tu, J., Wang, D., Zheng, X., & Liu, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.911368 · Cited by 27

Modulatory effects of adiponectin on the polarization of tumor-associated macrophages

Peng, J., Tsang, J. Y., Ho, D., Zhang, R., Xiao, H., Li, D., Zhu, J. J., Wang, F., Bian, Z., Lui, V. C. H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29485 · Cited by 27

Bone Sarcomas: From Biology to Targeted Therapies

Gaspar, N., Giannatale, A. D., Geoerger, B., Rédiní, F., Corradini, N., Entz‐Werlé, N., Tirode, F., Marec‐Bérard, P., Gentet, J., Laurence, V., et al. (2012) · Sarcoma · doi:10.1155/2012/301975 · Cited by 28

Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis

Kähkönen, T. E., Halleen, J. M., & Bernoulli, J. (2021) · Cells · doi:10.3390/cells10061529 · Cited by 26

Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies

Ying, H., Li, Z., Li, M.-P., & Liu, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217669 · Cited by 29

Re-calculating! Navigating through the osteosarcoma treatment roadblock

McGuire, J., Utset‐Ward, T. J., Reed, D. R., & Lynch, C. C. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.004 · Cited by 26

Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies

Vardon, A., Dandapani, M., Cheng, D., Cheng, P., Santo, C. D., & Mussai, F. (2017) · Oncotarget · doi:10.18632/oncotarget.18843 · Cited by 26

Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy

Cersosimo, F., Lonardi, S., Bernardini, G., Telfer, B., Mandelli, G. E., Santucci, A., Vermi, W., & Giurisato, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155207 · Cited by 280

Identification of Immune-Related Genes MSR1 and TLR7 in Relation to Macrophage and Type-2 T-Helper Cells in Osteosarcoma Tumor Micro-Environments as Anti-metastasis Signatures

Chen, Z., Huang, H., Wang, Y., Zhan, F., & Quan, Z. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.576298 · Cited by 18

Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma

Dumars, C., Ngyuen, J.-M., Gaultier, A., Lanel, R., Corradini, N., Gouin, F., Heymann, D., & Heymann, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13055 · Cited by 183

Tumor-associated macrophages in osteosarcoma

Zhao, Y., Zhang, B., Zhang, Q., Ma, X., & Feng, H. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100029 · Cited by 37

Macrophage-centered immunotherapy for osteosarcoma: mechanisms, repolarization, and translational strategies

Li, Z., Lin, D., Wu, L., Xu, W., Zhang, H., Zhuang, Z., Zhang, L., Chen, J., & Su, Z. (2026) · World Journal of Surgical Oncology · doi:10.1186/s12957-026-04288-5 · Cited by 3